These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22563779)

  • 21. Advances in the current treatment of autoimmune hepatitis.
    Czaja AJ
    Dig Dis Sci; 2012 Aug; 57(8):1996-2010. PubMed ID: 22476586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Autoimmune Hepatitis].
    Kim JK
    Korean J Gastroenterol; 2023 Feb; 81(2):72-85. PubMed ID: 36824035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of autoimmune hepatitis.
    Mayo MJ
    Curr Opin Gastroenterol; 2011 May; 27(3):224-30. PubMed ID: 21451411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
    Devlin SM; Swain MG; Urbanski SJ; Burak KW
    Can J Gastroenterol; 2004 May; 18(5):321-6. PubMed ID: 15152283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI; Akbar HO
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic strategies for autoimmune hepatitis.
    Manns MP; Strassburg CP
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.
    Czaja AJ
    Curr Pharm Des; 2011; 17(29):3120-40. PubMed ID: 21902661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.
    Selvarajah V; Montano-Loza AJ; Czaja AJ
    Aliment Pharmacol Ther; 2012 Oct; 36(8):691-707. PubMed ID: 22973822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Can J Gastroenterol; 2013 Sep; 27(9):531-9. PubMed ID: 24078938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of autoimmune hepatitis: a review of current and evolving therapies.
    Jothimani D; Cramp ME; Mitchell JD; Cross TJ
    J Gastroenterol Hepatol; 2011 Apr; 26(4):619-27. PubMed ID: 21073674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging treatments for autoimmune hepatitis.
    Czaja AJ
    Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):317-26. PubMed ID: 14561179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 36. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
    Giannakopoulos G; Verbaan H; Friis-Liby IL; Sangfelt P; Nyhlin N; Almer S;
    Dig Liver Dis; 2019 Feb; 51(2):253-257. PubMed ID: 30389427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current topics in autoimmune hepatitis.
    Muratori L; Muratori P; Granito A; Pappas G; Cassani F; Lenzi M
    Dig Liver Dis; 2010 Nov; 42(11):757-64. PubMed ID: 20615766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.
    Roth D; Colona J; Burke GW; Ciancio G; Esquenazi V; Miller J
    Transplantation; 1998 Jan; 65(2):248-52. PubMed ID: 9458023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
    Efe C; Hagström H; Ytting H; Bhanji RA; Müller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall HU; Muratori P; Gunşar F; Klintman D; Parés A; Heurgué-Berlot A; Schiano TD; Cengiz M; May-Sien Tana M; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1950-1956.e1. PubMed ID: 28603052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.